This is a non-core endpoint: only basic statistics are computed.
Phlebitis and thrombophlebitis of other sites, drug-induced
PHLEBI_THROMBOP_OTHER_SITES
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
25 |
4. Check minimum number of eventsNone |
25 |
5. Include endpointsNone |
25 |
6. Filter based on genotype QC (FinnGen only) |
25 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of other sites, drug-induced
based on the number of shared cases.
Similar with more cases:
- Phlebitis and thrombophlebitis (not including DVT)
- Venous thromboembolism
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 25 | 15 | 10 |
| Unadjusted period prevalence (%) | 0.00 | 0.01 | 0.00 |
| Median age at first event (years) | 50.45 | 48.30 | 53.67 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36304419) Bacteria [Presence] in Urine
15
51
5.85
4.53
4.0
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
14
49
5.22
3.98
4.1
2.6
e6/l
0.3
0.5
—
8
38
(3002582) Erythrocytes [#/volume] in Urine
14
57
4.31
3.13
4.1
2.7
e6/l
24.9
9.5
—
8
46
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
5
12.00
3.11
1.0
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
15
67
4.10
2.91
4.4
3.2
e6/l
6.1
48.3
—
9
49
(40768797) Stomach Pathology biopsy report
9
28
4.42
2.64
1.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
18
4.96
2.46
1.1
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
7
20
4.43
2.25
2.0
1.5
ug/g
49.6
77.7
—
7
15
(3044889) 12 lead EKG panel
20
128
3.80
2.22
4.7
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
15
4.90
2.18
7.0
3.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
71
3.21
2.06
4.1
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
11
5.37
2.04
1.6
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
17
4.29
1.97
5.3
5.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
0
44
0.00
1.72
0.0
4.0
—
1.0
—
0
5
(4035726)
5
16
3.63
1.51
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
6
23
3.10
1.47
1.2
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
12
66
2.57
1.40
4.8
3.5
mmol/l
2.3
2.3
0.04
12
58
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
33
0.00
1.27
0.0
8.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
7
30
2.84
1.24
1.4
1.8
umol/l
15.6
10.8
—
7
25
(3033658) Prothrombin time (PT) actual/Normal
9
49
2.30
1.15
2.6
4.0
%
87.2
90.4
—
9
49
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
0
29
0.00
1.06
0.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
28
0.00
1.05
0.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
7
40
2.04
0.80
1.1
1.8
pmol/l
484.1
516.2
—
7
31
(40760892) CBC W Ordered Manual Differential panel - Blood
7
42
1.92
0.76
2.7
6.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
26
2.15
0.75
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
19
0.00
0.63
0.0
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
80
0.53
0.58
3.2
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
12
87
1.73
0.56
5.1
5.6
%
0.6
0.7
0.07
12
80
(3023368) Bacteria identified in Blood by Culture
7
47
1.68
0.54
7.0
4.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
79
1.70
0.52
3.5
2.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
12
90
1.64
0.48
5.1
5.5
%
3.3
2.9
0.36
12
83
(3019069) Monocytes/100 leukocytes in Blood
12
90
1.64
0.48
5.1
5.9
%
8.6
8.1
0.26
12
83
(42870588) Differential panel, method unspecified - Blood
9
64
1.63
0.47
4.4
4.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
32
1.70
0.45
1.0
1.7
—
—
—
0
0
(3015736) pH of Urine
5
78
0.55
0.44
3.0
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
33
1.64
0.44
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
15
0.00
0.43
0.0
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
12
92
1.59
0.42
5.2
5.6
%
56.3
57.9
0.26
12
85
(3002173) Hemoglobin [Mass/volume] in Arterial blood
0
17
0.00
0.42
0.0
11.4
—
121.6
—
0
17
(40768804) Tissue Pathology biopsy report
11
83
1.58
0.41
1.6
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6
45
1.44
0.37
1.8
2.0
mg/l
2.6
3.4
—
6
38
(3026008) Bacteria identified in Urine by Culture
8
60
1.49
0.33
2.6
2.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
12
96
1.48
0.33
5.3
5.6
%
30.0
26.8
0.73
12
88
(40758558) Short blood count panel - Blood
8
63
1.40
0.32
6.5
6.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
11
0.00
0.22
0.0
3.1
—
27.4
—
0
11
(3019060) Gas panel - Arterial blood
0
10
0.00
0.22
0.0
5.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
10
0.00
0.22
0.0
10.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
10
0.00
0.22
0.0
3.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
13
0.00
0.21
0.0
13.7
—
94.9
—
0
13
(3041096) Erythrocytes [Presence] in Urine by Automated
7
57
1.32
0.21
4.4
3.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
14
0.00
0.20
0.0
2.5
—
0.1
—
0
14
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
15
133
1.32
0.18
4.6
3.7
—
—
—
0
0
(3013512) EKG study
5
63
0.74
0.09
3.8
4.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
80
0.83
0.08
4.4
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11
114
0.94
0.00
4.4
3.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
9
0.00
0.00
0.0
6.3
—
46.3
—
0
9
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
7.3
—
0
5
(44806118)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
5.3
—
24.7
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
5
53
0.93
0.00
5.6
4.0
estimate
0.0
0.0
—
5
16
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
1.6
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
62.4
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
164.3
—
0
7
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790048)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
8.8
—
0
6
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
0.6
—
0
7
(1761482) Bacteria [#/volume] in Urine by Culture
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
2.0
—
0
5
(4062490)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
0
8
0.00
0.00
0.0
8.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.8
—
197.6
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
30.7
—
0
8
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
0.2
—
0
5
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_OTHER_SITES – Phlebitis and thrombophlebitis of other sites, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).